Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate

Imatinib mesylate (IM) resistance is an emerging and major challenge in the treatment of patients with chronic myeloid leukaemia (CML). Resistance toward IM can be divided into BCR-ABL dependent pathways and BCR-ABL independent pathway. In this study, the BCRABL independent pathway was investigated;...

Full description

Saved in:
Bibliographic Details
Main Author: Razali, Ruzi Hamimi
Format: Thesis
Language:English
Published: 2015
Subjects:
Online Access:http://eprints.usm.my/39897/1/Dr_Ruzi_Hamimi_Razali_%28Medical_Genetics%29-24_pages.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!